Literature DB >> 14617239

Botulinum toxin injection inhibits myogenic tone and sympathetic nerve function in the porcine internal anal sphincter.

O M Jones1, J A Moore, A F Brading, N J Mc C Mortensen.   

Abstract

OBJECTIVE: Botulinum toxin is an effective treatment for anal fissure, though there is a lack of agreement over the optimal site for its injection. This reflects our current ignorance of its mechanism, and whether it has any action on the nerves of the internal anal sphincter (IAS). This study set out to resolve this issue through use of a pig model.
MATERIALS AND METHODS: Eight pigs were studied in pairs: one of each pair received a botulinum toxin injection into the anal sphincter, whilst the other acted as its control. Manometry was performed every two weeks under anaesthesia. Pigs were slaughtered at between four and six weeks after injection and the properties of the IAS compared in vitro.
RESULTS: Whilst maximum anal resting pressure (MARP) increased slowly in control pigs during the experimental period, reflecting weight gain, a fall was observed in treated pigs. In vitro, IAS strips from control pigs generated 400 mg of spontaneous tone per gram of tissue (+/- 45; standard error), compared to 250 (+/- 25) mg/g tissue from treated pigs (P < 0.01). Electric Field Stimulation at 50 Hz produced 150 (+/- 22) mg contraction/gram tissue in IAS strips from control pigs compared to 53 (+/- 13) mg/g tissue in treated pigs (P < 0.0005). This contractile response was blocked by guanethidine.
CONCLUSION: Botulinum toxin has a significant action on the IAS. It reduces myogenic tone and contractile responses of this tissue to sympathetic nerve stimulation. Further studies are required to clarify its mechanism of action more precisely.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617239     DOI: 10.1046/j.1463-1318.2003.00484.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  8 in total

1.  Towards safer treatments for benign anorectal disease: the pharmacological manipulation of the internal anal sphincter.

Authors:  Oliver M Jones
Journal:  Ann R Coll Surg Engl       Date:  2007-09       Impact factor: 1.891

2.  Botulinum Toxin Injection for Analgesic Effect after Hemorrhoidectomy: A Randomized Control Trial.

Authors:  Siripong Sirikurnpiboon; Paiboon Jivapaisarnpong
Journal:  J Anus Rectum Colon       Date:  2020-10-29

3.  Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells.

Authors:  Jagmohan Singh; Vaibhav Mehendiratta; Francesco Del Galdo; Sergio A Jimenez; Sidney Cohen; Anthony J DiMarino; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-09-24       Impact factor: 4.052

4.  Aging-associated oxidative stress leads to decrease in IAS tone via RhoA/ROCK downregulation.

Authors:  Jagmohan Singh; Sumit Kumar; Chadalavada Vijay Krishna; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

5.  Botulinum toxin treatment for anal fissure.

Authors:  Mohamed M Radwan; Khalil Ramdan; Ismail Abu-Azab; Fikri M Abu-Zidan
Journal:  Afr Health Sci       Date:  2007-03       Impact factor: 0.927

Review 6.  Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose-Dependent Efficiency? A Meta-Analysis.

Authors:  Adam Bobkiewicz; Wojciech Francuzik; Lukasz Krokowicz; Adam Studniarek; Witold Ledwosiński; Jacek Paszkowski; Michal Drews; Tomasz Banasiewicz
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

7.  Ultrasound guided injections of botulinum toxin type A into stellate ganglion to treat insomnia.

Authors:  Xu-Dong Ding; Zhi-Gang Ding; Wei Wang; Yan-Ping Liu; Jing Zhong; Hua-Xian Chen
Journal:  Exp Ther Med       Date:  2017-06-15       Impact factor: 2.447

8.  Proctalgia and constipation secondary to hypertrophic polyglucosan inclusion body myopathy of the internal anal sphincter: a case report.

Authors:  Ioanna G Panagiotopoulou; Richard Miller; Michael P Powar; James Y H Chan; R Justin Davies
Journal:  J Med Case Rep       Date:  2018-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.